Basic research and development of de novo-designed peptide/fluorinated carbon hybrid artificial lung surfactant

从头设计肽/氟化碳杂化人工肺表面活性剂的基础研究与开发

基本信息

项目摘要

This study is aimed to investigate the interfacial behavior of a mimic peptide (Hel/3-5) of human surfactant protein B, in a phospholipid (DPPC) and various lipid mixtures and to examine the correlation between in vitro surface activity and in vivo lung function of artificial surfactant preparation. The new finding is following terms.I: DPPC alone has some defects in pulmonary functions such as rapid respreading, adsorption, and large hysteresis. However, addition of a small amount of He113-5 to DPPC led to improvement in adsorption of DPPC, and enlargement of a hysteresis of surface pressure (π)-area (A) curve for DPPC reversibly, as shown a substitute for SP-B.II: Additive PG works selectively and electrostatically interact with cationic Hel13-5 during the squeeze-out process and then 3-D aggregates containing Hel13-5 and being formed just below the surface monolayer. This formation contributes to the stability of DPPC monolayers. On the other hand, PA components are not mainly squee … More zed out of surface monolayers together with He113-5, and form the close-packed monolayer with DPPC at the interface.III: Surface chemistry (Langmuir isotherms, fluorescent images, temperature dependence, and hysteresis curves) of the artificial preparation and Surfacten (commercially available for RDS patients) has been made for the comparison between them. Above all, this artificial preparation is comparative to Surfacten in terms of surface activity and the interfacial behavior.IV: In vivo, efficacy of this preparation was elucidated in a rat lung and a surfactant-deficient rat. The preparations containing 2.5wt% Hel13-5 was used for the in vivo measurements of dynamic lung compliances and quasi-static pressure-volume curves. The preparation with 2.5wt% Hel13-5 was equivalent to Surfacten with respect to improving lung function and mechanics for the surfactant-deficient rat.Finally, this pulmonary surfactant substitutes will contribute to tailoring surfactant preparations to various states of surfactant deficiency, insufficiency and inactivation. Less
本研究旨在研究人表面活性物质蛋白B的模拟多肽(Hel/3-5)在磷脂(DPPC)和不同的脂质混合物中的界面行为,并考察人工表面活性物质制剂的体外表面活性与体内肺功能的相关性。新的发现如下:I:DPPC本身在肺功能方面存在一些缺陷,如快速再扩散、吸附和大滞后。然而,加入少量的He113-5使DPPC的吸附性能得到改善,DPPC的表面压力(π)-面积(A)曲线的滞后性可逆地增大,显示出替代SP-B的作用。II:添加剂PG选择性地起作用,在挤出过程中与阳离子HEL13-5发生静电作用,然后含有HEL13-5的三维聚集体在表面单分子层正下方形成。这种形成有助于DPPC单分子膜的稳定性。另一方面,功放组件不是主要的Squee…更多的表面单层与He113-5一起剥离,并与DPPC在界面形成紧密堆积的单层。III:人工制剂和Surfacten(RDS患者可买到的)的表面化学(Langmuir等温线、荧光图像、温度依赖性和滞后曲线)进行了比较。最重要的是,该人工制剂在表面活性和界面行为方面与Surfacten相当。IV:在体内,该制剂的有效性在大鼠肺和表面活性物质缺乏的大鼠中得到阐明。含2.5wt%Hel13-5的制剂用于动态肺顺应性和准静态压力-体积曲线的活体测量。2.5wt%Hel13-5制剂在改善肺表面活性物质缺乏大鼠的肺功能和机械性能方面与表面活性物质相当,最终,这种肺表面活性物质替代品将有助于使表面活性物质制剂适应表面活性物质缺乏、不足和失活的不同状态。较少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Two-component Langmuir monolayers of single-chain partially fluorinated amphiphiles with dipalmitoylphosphatidylcholine (DPPC).
Interfacial Properties of Binary Monolayers of Perfluorocarboxylic Acids and DMPE or DPPG.
全氟羧酸和 DMPE 或 DPPG 二元单分子层的界面性质。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hiromichi Nakahara;Hiroki Yokoyama;Osamu Shibata
  • 通讯作者:
    Osamu Shibata
Interfacial Roles of Phosphatidylglycerol in Synthetic Pulmonary Surfactant Preparations.
磷脂酰甘油在合成肺表面活性剂制剂中的界面作用。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hiromichi Nakahara;Sannamu Lee;Gohsuke Sugihara;Osamu Shibata
  • 通讯作者:
    Osamu Shibata
ポリエキシエチレンアルキルエーテル(C14E18)の可溶可能について
关于聚氧乙烯烷基醚(C14E18)的溶解度
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Minami Tsuji;Hiromichi Nakahara;Yoshikiyo Moroi;Osamu Shibata;保田 和樹;中原 広道;津地 みなみ;佐藤 由紀子
  • 通讯作者:
    佐藤 由紀子
完全フッ素化カルボン酸/リン脂質(DMPE)の二成分単分子膜挙動
全氟化羧酸/磷脂 (DMPE) 的二元单层行为
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Minami Tsuji;Hiromichi Nakahara;Yoshikiyo Moroi;Osamu Shibata;保田 和樹;中原 広道;津地 みなみ;佐藤 由紀子;横山 宏樹
  • 通讯作者:
    横山 宏樹
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIBATA Osamu其他文献

Phase-Difference Compensation and Nonuniform Pulse Transmission for Accurate Real-Time Moving Object Tracking
用于精确实时移动物体跟踪的相位差补偿和非均匀脉冲传输

SHIBATA Osamu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIBATA Osamu', 18)}}的其他基金

Development of Innovative Targeting Hybrid Artificial Pulmonary Surfactant Preparations by Nanomedicine
纳米医学创新靶向混合人工肺表面活性剂制剂的开发
  • 批准号:
    26350534
  • 财政年份:
    2014
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Innovative Targeting Artificial pulmonary surfactant preparations by Nanomedicine
纳米医学创新靶向人工肺表面活性物质制剂的开发
  • 批准号:
    23510134
  • 财政年份:
    2011
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of contraction/relaxation of airway smooth muscle : relationship between β-antagonist and Rho-kinase pathway
气道平滑肌收缩/舒张机制:β-拮抗剂与Rho激酶途径的关系
  • 批准号:
    19591804
  • 财政年份:
    2007
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of airway smooth muscle contraction : physio-pharmacologic factors and intracellular signaling pathway
气道平滑肌收缩机制:生理药理学因素和细胞内信号通路
  • 批准号:
    15591638
  • 财政年份:
    2003
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of Intravenous anesthetics on Phosphatidylinositol Response of Spinal Descending Inhibitory Pathways of Rat
静脉麻醉药对大鼠脊髓下降抑制通路磷脂酰肌醇反应的影响
  • 批准号:
    10671421
  • 财政年份:
    1998
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ROLES OF PHOSPHATIDYLINOSITOL IN THE MECHANISMS INVOLVED IN THE AIRWAY SMOOTH MUSCLE RELAXATION INDUCED BY ATP-SENSITIVE POTASSIUM CHANNEL OPENERS
磷脂酰肌醇在 ATP 敏感钾通道开放剂诱导的气道平滑肌松弛机制中的作用
  • 批准号:
    08671750
  • 财政年份:
    1996
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Study on Two Dimensional Dynamic Process of Ionic Surfactants Composed of Fluorocarbon and Hydrocarbon Ions
氟碳烃离子组成的离子表面活性剂二维动态过程研究
  • 批准号:
    07672318
  • 财政年份:
    1995
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estimation of ultraviolet radiation as a limiting factor for vertical distribution of plants by studying their ultraviolet resistance.
通过研究植物的紫外线抵抗力来估计紫外线辐射作为植物垂直分布的限制因素。
  • 批准号:
    02804054
  • 财政年份:
    1990
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Study on Infrared Spectrophotometer for Langmuir monolayer
Langmuir单层膜红外分光光度计的研究
  • 批准号:
    13554027
  • 财政年份:
    2001
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Umorientierungsprozesse in hexatischen Langmuir-Monolayer-Phasen unter dem Einfluß lokaler Temperaturgradienten
局部温度梯度影响下六方朗缪尔单层相的重新取向过程
  • 批准号:
    5230834
  • 财政年份:
    2000
  • 资助金额:
    $ 10.09万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了